Madrigal Pharmaceuticals Inc (MDGL)
215.99
+5.91
(+2.81%)
USD |
NASDAQ |
May 02, 16:00
215.99
0.00 (0.00%)
After-Hours: 18:42
Madrigal Pharmaceuticals Cash from Operations (Quarterly): -79.93M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -79.93M |
| September 30, 2023 | -84.92M |
| June 30, 2023 | -75.31M |
| March 31, 2023 | -84.07M |
| December 31, 2022 | -58.52M |
| September 30, 2022 | -59.07M |
| June 30, 2022 | -57.36M |
| March 31, 2022 | -49.91M |
| December 31, 2021 | -48.05M |
| September 30, 2021 | -45.56M |
| June 30, 2021 | -46.88M |
| March 31, 2021 | -43.43M |
| December 31, 2020 | -54.95M |
| September 30, 2020 | -47.85M |
| June 30, 2020 | -24.26M |
| March 31, 2020 | -30.51M |
| December 31, 2019 | -12.28M |
| September 30, 2019 | -11.32M |
| June 30, 2019 | -11.54M |
| March 31, 2019 | -6.478M |
| December 31, 2018 | -6.265M |
| September 30, 2018 | -5.238M |
| June 30, 2018 | -5.36M |
| March 31, 2018 | -8.644M |
| December 31, 2017 | -5.945M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.951M |
| June 30, 2017 | -7.65M |
| March 31, 2017 | -3.771M |
| December 31, 2016 | -5.28M |
| September 30, 2016 | -9.243M |
| June 30, 2016 | -2.647M |
| March 31, 2016 | -0.438M |
| December 31, 2015 | -1.096M |
| September 30, 2015 | 34.46M |
| June 30, 2015 | -17.73M |
| March 31, 2015 | -18.78M |
| December 31, 2014 | -19.22M |
| September 30, 2014 | -18.57M |
| June 30, 2014 | -20.87M |
| March 31, 2014 | -20.27M |
| December 31, 2013 | -18.69M |
| September 30, 2013 | -16.59M |
| June 30, 2013 | -19.92M |
| March 31, 2013 | -22.21M |
| December 31, 2012 | -12.52M |
| September 30, 2012 | -13.26M |
| June 30, 2012 | -13.10M |
| March 31, 2012 | -15.25M |
| December 31, 2011 | -10.49M |
| September 30, 2011 | -11.82M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-84.92M
Minimum
Sep 2023
-11.32M
Maximum
Sep 2019
-48.72M
Average
-48.05M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 1.166B |
| Viking Therapeutics Inc | -6.134M |
| Akero Therapeutics Inc | -48.63M |
| 89bio Inc | -34.29M |
| Geron Corp | -40.94M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -362.12M |
| Cash from Financing (Quarterly) | 479.92M |
| Free Cash Flow | -325.71M |
| Free Cash Flow Per Share (Quarterly) | -4.095 |
| Free Cash Flow Yield | -8.07% |